NCT00676104

Brief Summary

The primary goal of this project is to demonstrate the feasibility and clinical benefits of a new rapid treatment for secondary treatment for secondary brain injury called Discrete Cerebral Hypothermia System by CoolSystems, Inc., Berkley, CA. This device induced hypothermia in the adult brain without significant whole body hypothermia. Discrete Cerebral Hypothermia System holds a great potential for protecting the brain from the devastating secondary complications of trauma without the associated deleterious system effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jul 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2006

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 12, 2008

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2008

Completed
Last Updated

December 20, 2013

Status Verified

December 1, 2013

Enrollment Period

1.1 years

First QC Date

May 8, 2008

Last Update Submit

December 19, 2013

Conditions

Keywords

Traumatic Brain InjuryTraumaHypothermia

Outcome Measures

Primary Outcomes (1)

  • Perform a comparative analysis of outcome (Glasgow Outcome Score)

    Day 1, day 2, day 3, day 7, day 14, day 21, day 28 and 1 month after injury

Secondary Outcomes (4)

  • The effectiveness of the Discrete Cerebral Hypothermia System by CoolSystems in maintaining a significant gradient between the core and brain temperatures in study population.

    within 3 days after injury

  • Functional Independence Measure

    Day 1, day 2, day 3, day 7, day 14, day 21, day 28 and 1 month after injury

  • Mortality

    Day 1, day 2, day 3, day 7, day 14, day 21, day 28 and 1 month after injury

  • Confirm the effectiveness of the Discrete Cerebral System in reducing internal brain temperature

    within 3 days after injury

Study Arms (2)

Treatment

EXPERIMENTAL
Device: CoolSystems Discrete Cerebral Hypothermia System

Control

SHAM COMPARATOR
Device: CoolSystems Discrete Cerebral Hypothermia System

Interventions

The CoolSystems Discrete Cerebral Hypothermia System (DCHS) will be removed from the patients head after 48 hours.

ControlTreatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is treated for severe traumatic brain injury at Grady Health System, GCS \< 8
  • Patient is \>18 years of age
  • Patient requires an Intracranial Pressure (ICP) Probe (part of their routine treatment)
  • Patient is able to receive Discrete Cerebral Hypothermia within 48-hours of hospital admission
  • Patient and/or guardian must speak English (in order to ensure proper Informed Consent)
  • Patient and/or guardian/family must sign an Informed Consent

You may not qualify if:

  • Unwillingness or inability of patient and/or guardian/ family to sign an informed consent
  • Physical placement of cooling cap impedes routine treatment
  • Patient has a core body temperature of 36 degrees C or less at time of assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University School of Medicine, Grady Health System campus

Atlanta, Georgia, 30303, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticWounds and InjuriesHypothermia

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Odette A Harris, MD, MPH

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Designated Investigator

Study Record Dates

First Submitted

May 8, 2008

First Posted

May 12, 2008

Study Start

July 1, 2006

Primary Completion

August 1, 2007

Study Completion

October 1, 2008

Last Updated

December 20, 2013

Record last verified: 2013-12

Locations